|
Phillip M. Satow has been a member of Crucell’s Supervisory Board since its incorporation. He spent 14 years at Pfizer, Inc. (PFE-NYSE) where his last position was Vice President, Pharmaceutical Development, Pfizer Europe. From 1985 to 1997, he was Executive Vice President Marketing at Forest Laboratories, Inc. From 1998 to 1999 he was President of Forest Pharmaceuticals, Executive Vice President of Forest Laboratories Inc. and a member of its board of directors. Mr Satow currently serves on the boards of Forest Laboratories Inc. (FRX), Eyetech Pharmaceuticals Inc. (EYET) and is Chairman and CEO of JDS Pharmaceuticals LLC, a privately held pharmaceutical company. Mr Satow received a Masters in Economics from Georgetown University. | 